| High resolution anatomical mapping of gene expression using targeted in situ sequencing | |||||
|
Fri20 Dec11:00am(30 mins)
|
|
|
Dr Mats Nilsson | ||
| Session : Disruptive technologies | |||||
| Room: Hall 1B | |||||
| Development of an Image-Based HCS-Compatible Method for Endothelial Barrier Function Assessment | |||||
|
Fri20 Dec11:30am(30 mins)
|
|
|
Dr Sun Yung | ||
| Session : Disruptive technologies | |||||
| Room: Hall 1B | |||||
| Live cell compatible super resolution fluorescence microscopy for 3D imaging | |||||
|
Fri20 Dec12:00pm(30 mins)
|
|
|
Ilaria Testa |
|
Francesca Pennacchietti |
| Session : Disruptive technologies | |||||
| Room: Hall 1B | |||||
| Single-cell CRISPR screens in primary human T cells | |||||
|
Fri20 Dec12:30pm(15 mins)
|
|
|
Dr Tilmann Buerckstuemmer | ||
| Session : Disruptive technologies | |||||
| Room: Hall 1B | |||||
| R&D at the New Speed of Science: Accelerate your R&D Transformation with Benchling | |||||
|
Fri20 Dec12:45pm(5 mins)
|
|
|
Tali Bloom | ||
| Session : Disruptive technologies | |||||
| Room: Hall 1B | |||||
| Introducing an electronic sensor to measure affinity of intermolecular interactions | |||||
|
Fri20 Dec12:50pm(5 mins)
|
|
|
Dr Sylwia Mankowska | ||
| Session : Disruptive technologies | |||||
| Room: Hall 1B | |||||
| All Human Drug Research Solutions | |||||
|
Fri20 Dec12:55pm(5 mins)
|
|
|
Mr Paul Gallant | ||
| Session : Disruptive technologies | |||||
| Room: Hall 1B | |||||
| Chemical Materials Design | |||||
|
Fri20 Dec02:30pm(30 mins)
|
|
|
Dr Ben Slater | ||
| Session : Disruptive technologies | |||||
| Room: Hall 1B | |||||
| Quantum computing: a new frontier in drug discovery? | |||||
|
Fri20 Dec03:00pm(30 mins)
|
|
|
Sam Genway | ||
| Session : Disruptive technologies | |||||
| Room: Hall 1B | |||||
| A structural biology community assessment of AlphaFold 2 applications | |||||
|
Fri20 Dec03:40pm(30 mins)
|
|
|
Pedro Beltrao | ||
| Session : Disruptive technologies | |||||
| Room: Hall 1B | |||||
| MELLODDY: privacy-preserving federated machine learning across pharma partners | |||||
|
Fri20 Dec04:10pm(30 mins)
|
|
|
Dr Hugo Ceulemans | ||
| Session : Disruptive technologies | |||||
| Room: Hall 1B | |||||
